Who owns Verrica Pharmaceuticals Inc?
- Ticker: VRCA
- CUSIP Number: 92511w207
Tip: Access positions for across all investors
Analyze quarterly positions in Verrica Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Verrica Pharmaceuticals stock
Who bought or sold Verrica Pharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Caligan Partners | 924k | $4.0M | 100% | Sep 2025 |
|
| Armistice Capital | 639k | $2.8M | 100% | Sep 2025 |
|
| Boothbay Fund Management | 281k | $1.2M | 100% | Sep 2025 |
|
| Vanguard Group | 225k | $971k | 100% | Sep 2025 |
|
| Sovran Advisors | 74k | $261k | 100% | Sep 2025 |
|
| Millennium Management | 72k | $310k | 100% | Sep 2025 |
|
| Geode Capital Management | 68k | $292k | 100% | Sep 2025 |
|
| UBS Group | 42k | $179k | 100% | Sep 2025 |
|
| Renaissance Technologies | 29k | $126k | 100% | Sep 2025 |
|
| Mariner Wealth Advisors | 25k | $106k | 100% | Sep 2025 |
|
| State Street Corporation | 21k | $89k | 100% | Sep 2025 |
|
| Northern Trust | 20k | $86k | 100% | Sep 2025 |
|
| Bridgeway Capital Management | 12k | $52k | 100% | Sep 2025 |
|
| BlackRock | 6.1k | $27k | 100% | Sep 2025 |
|
| FMR | 3.3k | $14k | 100% | Sep 2025 |
|
| Tower Research Capital | 1.5k | $6.7k | 100% | Sep 2025 |
|
| Capital Analysts | 1.5k | $6.0k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 1.2k | $5.0k | 100% | Sep 2025 |
|
| Salomon & Ludwin | 290.00 | $1.4k | 100% | Sep 2025 |
|
| New England Capital Financial Advisors | 200.00 | $862.000000 | 100% | Sep 2025 |
|
| NISA Investment Advisors | 142.00 | $612.005800 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 124.00 | $534.006000 | 100% | Sep 2025 |
|
| Pnc Financial Services | 102.00 | $439.099800 | 100% | Sep 2025 |
|
| Covestor | 54.00 | $0 | 100% | Sep 2025 |
|
| Optiver Holding B.V. | 31.00 | $134.000600 | 100% | Sep 2025 |
|
| CWM | 28.00 | $0 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 9.00 | $37.999800 | 100% | Sep 2025 |
|
| Group One Trading | 3.00 | $12.999900 | 100% | Sep 2025 |
|
| MAI Wealth Advisors | 2.00 | $9.000000 | 100% | Sep 2025 |
|
| Barclays | 1.00 | $4.000000 | 100% | Sep 2025 |
|
Who sold out of Verrica Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Jun 2025 | 124k | $66k |
| Beck Mack & Oliver | Jun 2025 | 70k | $37k |
| EverSource Wealth Advisors | Jun 2025 | 49.00 | $25.999400 |
| SBI Securities | Jun 2025 | 2.00 | $1.000000 |